Nucleophosmin 1 (NPM1) mutations are the most common single gene abnormality detected in adult acute myeloid leukemia (AML) and might represent the initiating event for AML development in about 60% of AML patients without causative cytogenetic abnormalities [1]. This evidence concerns the gene NPM1 and acute myeloid leukemia.